There is a necessity to better characterize uveal melanoma (UM) tumors according to their metastasis potential at an early stage. In this study we report the identification of potential biomarkers by a combination of proteomics-related approaches: the characterization of UM cell secretomes, the analysis of UM autoantibodies, and the differential depleted serum proteome analysis. We describe a possible role of cathepsin D, syntenin, and gp100 in UM as potential biomarkers.
引用
收藏
页码:2802 / 2811
页数:10
相关论文
共 68 条
[1]
All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1